LNTH Stock Analysis: Buy, Sell, or Hold?
LNTH - Lantheus Holdings, Inc
$99.64
-1.36 (-1.35%)
▼
5d:
-4.94%
30d:
-8.55%
90d:
+17.75%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
3d
Get Alerted When LNTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: LNTH shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: LNTH shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$143.25
Based on 10.9% avg growth
INTRINSIC VALUE TODAY
$88.94
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LNTH is currently trading at $99.64, which is considered oversold relative to its 30-day fair value range of $103.02 to $108.54. From a valuation perspective, the stock is trading at a premium (Forward PE: 15.8) compared to its historical average (13.6). At these levels, the market is pricing in 5.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LNTH is showing support break momentum. The price is currently testing key support at $98.81. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $112.75 (+13.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LNTH is showing support break momentum. The price is currently testing key support at $98.81. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $112.75 (+13.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$103.02 -
$108.54
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($112.75)
- NEUTRAL: Trading at premium valuation - market expects 5.2% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$103.02 -
$108.54
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$98.81
Resistance Level
$109.48
Current Trend
Support Break
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.79
Wall Street Target
$112.75
(+13.2%)
Revenue Growth (YoY)
1.2%
Earnings Growth (YoY)
76.5%
Profit Margin
18.1%
Valuation Premium vs History
+5.2% premium
PE vs Historical
15.8 vs 13.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.2%
(market-implied from PE analysis)
1-Year Target
$104.82
(+5%)
2-Year Target
$110.27
(+11%)
3-Year Target
$116.01
(+16%)
3-Yr Target (if PE normalizes)
(PE: 16→14)
PE COMPRESSION
$99.90
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 17.8%)
$213.85
(+115%)
Base:
(SPY PE: 15.8, Growth: 17.8%)
$162.91
(+64%)
Bear:
(PE: 13.4, Growth: 17.8%)
$138.47
(+39%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 23.88 | Current EPS (TTM): $4.23
Bull Case
$165.72
(+66%)
Analyst growth 49.2%, PE expands to 26.3
Base Case
$150.65
(+51%)
Market implied 49.2%, PE stable at 23.9
Bear Case
$68.68
(-31%)
Severe decline -20.0%, PE contracts to 20.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 4:35 PM ET
Data refreshes hourly during market hours. Next update: 5:35 PM
Data refreshes hourly during market hours. Next update: 5:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LNTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$211 | 60 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$112 | 52 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$663 | 48 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 55 HOLD |
Advanced LNTH Option Strategies
Professional options setups generated by AI based on today's LNTH price and gamma walls.
